Price $117.65 |
Market Cap
1.44B
|
Sector Health Care |
Div. Growth
20.20%
|
|
P/E
49.6
|
P/B
6.26
|
P/S
3.09
|
Dividend %
1.00%
|
|
P/CF
-
|
P/FCF
29.8
|
Op. Cash Flow
65.5K
|
FCF
3.8
|
|
Op. Margin
14.40%
|
Net Margin
6.20%
|
ROE
13.20%
|
ROI
19.90%
|
|
ROA
5.70%
|
EPS Growth
59.30%
|
Current Ratio
1.9
|
Debt/Equity
17.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Champions Oncology Inc (CSBR) | $7.93 | - | - | 94.6M | Strong Buy |
| Diversicare Healthcare Service (DVCR) | $2.26 | - | 10.00% | 14.7M | Strong Buy |
| NantHealth Inc (NH) | $1.31 | - | - | 113.9M | Strong Buy |
| CYANOTECH CORP (CYAN) | $2.40 | - | - | 13.6M | Strong Buy |
| Novelion Therapeutics Inc (USA (NVLNF) | $0.70 | - | - | 14.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
